Signature gene expression profile of triclosan-resistant Escherichia coli
Authors:
Open Access
- 21 April 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (6) , 1171-1177
Abstract
To gain further insight into the defence mechanisms against triclosan in a mutant derived from an Escherichia coli strain carrying the triclosan-resistant target enzyme, FabI(G93V). An E. coli imp4231 FabI(G93V) strain was constructed by replacing intact fabI with a linear DNA cassette, fabI(G93V)-CmR, that contains a single mutation, GGT to GTT, at codon 93 of fabI(G93V) and a chloramphenicol resistance gene (CmR) as a marker for the mutant allele by a Red-mediated recombination system. Using this E. coli imp4231 FabI(G93V) strain, nitrosoguanidine (NTG) mutagenesis was performed to generate E. coli IFNs [imp4231 FabI(G93V) treated with NTG] displaying higher MICs of triclosan than its parent strain. The genes overexpressed in E. coli IFN4 were identified by DNA microarray analysis. An E. coli imp4231 FabI(G93V) strain displays ∼400-fold increased MICs of triclosan (MIC ∼ 8 mg/L) compared with the parent strain (MIC ∼ 0.02 mg/L). Furthermore, E. coli IFN4 has the highest MIC of triclosan (MIC ∼ 80 mg/L). DNA microarray analysis of E. coli IFN4 shows that many genes involved in the biosynthesis of membrane proteins, including transporters, reductases/dehydrogenases and stress response regulators, were highly expressed in the mutant. These results strongly indicate that E. coli IFN cells might protect themselves from triclosan by activating various defence mechanisms, such as (i) changing efflux activities; (ii) capturing the triclosan; and (iii) increasing the expression of important regulators or metabolic enzymes.Keywords
This publication has 22 references indexed in Scilit:
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilmsCanadian Journal of Microbiology, 2006
- Chemical ConditionalityCell, 2005
- Similarities and differences in the responses of microorganisms to biocidesJournal of Antimicrobial Chemotherapy, 2003
- Mannopeptimycins, New Cyclic Glycopeptide Antibiotics Produced by Streptomyces hygroscopicus LL-AC98: Antibacterial and Mechanistic ActivitiesAntimicrobial Agents and Chemotherapy, 2003
- Membranotropic Effects of the Antibacterial Agent TriclosanArchives of Biochemistry and Biophysics, 2001
- One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR productsProceedings of the National Academy of Sciences, 2000
- Triclosan: A review of effectiveness and safety in health care settingsAmerican Journal of Infection Control, 2000
- Overexpression ofmarA, soxS, oracrABproduces resistance to triclosan in laboratory and clinical strains ofEscherichia coliFEMS Microbiology Letters, 1998
- Triclosan: Applications and safetyAmerican Journal of Infection Control, 1996